Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ADVL 1515: A Phase 1 Study of LY2606368, A CHK 1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, Including CNS Tumors
Grant
Overview
Overview
Date/time Interval
June 28, 2017 - June 27, 2020
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
6500.00
Direct Costs
5000.00
Sponsor Award Id